Reprogramming autologous skeletal myoblasts to express cardiomyogenic function. Challenges and possible approaches

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Cell Biology

Background:

• Cell transplantation is a promising therapy for myocardial infarction.
• Autologous skeletal myoblasts offer advantages like reduced immunogenicity and better ischemic tolerance.
• Existing evidence suggests potential functional improvement in heart function post-transplantation.

Purpose of the Study:

• To review challenges in reprogramming skeletal myoblasts into functional cardiomyocytes.
• To explore strategies for achieving cardiomyogenic function in transplanted skeletal myoblasts.
• To address limitations in skeletal myoblast cell transplantation efficacy.

Main Methods:

• Histological analysis of transplanted cells.
• Assessment of cardiac-specific antigen expression.
• Evaluation of intercalated disc formation and electromechanical coupling.

Main Results:

• Transplanted skeletal myoblasts do not transdifferentiate into cardiomyocytes in situ.
• Lack of cardiac-specific antigen expression and intercalated discs observed.
• Cells differentiate into myotubes not electromechanically coupled to host cardiomyocytes.

Conclusions:

• Skeletal myoblast transplantation efficacy is limited by the failure to form functional cardiomyocytes.
• Reprogramming skeletal myoblasts to adopt cardiomyogenic properties is crucial for therapeutic success.
• Further research into reprogramming strategies is needed to enhance cell therapy for myocardial infarction.